Abstract: A pharmaceutical, orally applicable composition is described, whereby the solid composition contains at least one antacid active ingredient and/or at least one H.sub.2 -antagonist, at least one disintegrant, as well as at least one usual pharmaceutical additional ingredient. Furthermore said composition contains at least one ingredient that accelerates the decomposition of said composition in the mouth or in a liquid, whereby said ingredient is a water-soluble amino acid, a water-soluble amino acid derivative and/or a water-soluble amino acid salt.

Abstract: A pharmaceutical, orally applicable composition is described, whereby the solid composition contains at least one active ingredient, at least one disintegrant, as well as at least one usual pharmaceutical additional ingredient. Furthermore said composition contains at least one ingredient that accelerates the decomposition of said composition in the mouth or in a liquid, whereby said ingredient is a water-soluble amino acid, a water-soluble amino acid derivative and/or a water-soluble amino acid salt.

Abstract: The invention relates to a solid phospholipid composition with a high phosphatidylcholine content which, in addition to the corresponding phospholipids, contains Palatinit and if appropriate one or more other auxiliaries, and a process for its preparation and its use as an oral presentation form.

Abstract: Process and device for applying markings (9) and/or providing break notches on moulded items or tablets (4) by means of laser beams. The installation (16) which produces the laser beam (3) is arranged on a tablet-producing press, to which it is functionally connected by synchronization systems (18). A deflection system (17) is arranged on the die support (5) of the press in order to deflect the laser beam (3) onto the surface of the moulded item or tablet (4). The laser (16) is provided with an optical system (15) having interchangeable masks provided with openings through which the laser beam passes (3).

Abstract: Stable pharmaceutical preparations comprising amitriptylin oxide dihydrate as an active substance and an organic acid from the group of hydroxy carboxylic acids, ketocarboxylic acids or amino acids as a stabilizer besides conventional pharmaceutical auxiliaries and carrier substances.